TERN

XNAS

TERNS PHARMACEUTICALS INC

Avg. sentiment

0.60bullish

1 news · 90d

7d trend

0.60—

1 news · vs previous 7d (—)

Breakdown

↑ 1• 0↓ 0

Sentiment scores computed by AI · Not investment advice.

Price

Sentiment (7d avg)

1 news · hover dots for details

News · 1

SeekingAlpha4/24/2026, 1:18:21 PM
Merck acquisition of Terns passes HSR waiting period expiration
Merck's proposed acquisition of Terns Pharmaceuticals has cleared a key regulatory hurdle, with the Hart-Scott-Rodino (HSR) antitrust waiting period expiring without a challenge. This indicates U.S. antitrust regulators have no objection to the deal, moving it closer to completion. No revised deal terms or timeline for closing were mentioned in the article.
AI-generated content for informational purposes only. Not investment advice.
Sentiment 0.60Relevance 100%